Pittsburgh, PA – (April 30, 2021) – The Bladder Health Foundation announces the rollout of the first on-line patient registry for pelvic radiation cancer survivors. The online registry is located at www.radiationcystitis.org.
The Bladder Health Foundation, with support from Lipella Pharmaceuticals Inc., is promoting the awareness of a serious bladder health condition, hemorrhagic cystitis, which affects many cancer survivors who received pelvic radiation, including survivors of prostate, uterine/cervical and colon cancers. Hemorrhagic cystitis symptoms including painful urinary bleeding.
About the Bladder Health Foundation.
Created in 2012, the Bladder Health Foundation has been promoting awareness of bladder conditions with unmet needs including: interstitial cystitis, radiation cystitis, underactive bladder and neurogenic bladder dysfunction. These urologic morbidities can significantly affect the quality of life for cancer survivors.
About Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc. is a clinical stage pharmaceutical company with a focus on capital efficient therapeutic development opportunities, including the proprietary repositioning of generics for rare, morbid diseases that currently have no adequate treatments, including hemorrhagic cystitis. Additional information is available at www.lipella.com.
Contacts
Allison Houck
Lipella Pharmaceuticals Inc.
412-894-1853
info@lipella.com
Source: Lipella Pharmaceuticals Inc.
Keywords: patient registry, hemorrhagic cystitis; radiation cystitis; cancer survivorship
